KA Imaging achieves Health Canada license and FDA clearance for innovative X-ray technology

Wednesday, September 30, 2020

Digital X-ray technology developed by a University of ݮƵ spinoff company has won approval from Health Canada.

A medical device licence issued for Reveal 35C, a dual-energy X-ray detector created by, follows clearance from the Food and Drug Administration in the United States earlier this month.

“Getting this Health Canada licence is a major step forward for KA Imaging, especially coupled with the recent FDA clearance,” Amol Karnick (BASc '95), an engineering alumnus who is president and CEO of the company, said in a media release.

Sample images made with X-ray technology developed by ݮƵ Engineering startup KA Imaging.

Sample images made with X-ray technology developed by ݮƵ startup KA Imaging.

KA Imaging was founded in 2015 by Karnickand fellow alumni Sina Ghanbarzadeh (MASc '14) andKarim S. Karim(BASc '99, PhD '03), a professor of electrical and computer engineering and executive director of theCentre for Bioengineering and Biotechnologyat ݮƵ.

The company’s flagship product is an inexpensive, portable X-ray detector that can differentiate between bone and soft tissue in a single exposure.

It is now being tested on lung cancer patients at Grand River Hospital in Kitchener and for detection of pneumonia, including cases caused by COVID-19, at a Toronto-based hospital.

Full article: [ݮƵ Stories]